Talk with Lao Bi about Chinese medicine -- the story of "great leap forward" of Chinese Medicine

From 2003 to 2007, because of the well-known "story of that era" [Note 1], the "modernization" of the dosage form of Chinese patent medicine, boosted by the "market economy", formed a "great leap forward" For example, around a "Banlangen", God generally changes granules, tablets, syrups, injections, lozenges, chewable tablets, effervescent tablets, dispersible tablets, capsules, dropping pills, eye drops, etc., which are numerous and dazzling Under a "Banlangen" item, there are as many as 1213 document numbers This "great leap forward" made the number of varieties of Chinese patent medicines in China suddenly rise to more than 10000, and the total number of document numbers exceeded 60000 (specific numbers have not been verified in detail) Fortunately, in 2007, the state imposed a "heavy code" on the "disorder of drug registration numbers", and about 65000 (including chemical drugs) registration approvals were timely "closed and strictly examined" Otherwise, from December 31, 2001, when the State Food and drug administration carried out a unified renewal of approval numbers to the introduction of the new "drug registration management measures" in 2007, the "three peaks and three waves" of registration review backlog only once Today, the number of varieties of Chinese patent medicines in China will create another "miracle on earth" for at least 8 years - it's not a "thing" to produce 3000 new Chinese patent medicines in one Anti Japanese War cycle On the morning of July 10, 2007, Zheng Xiaoyu, former director of the State Food and drug administration, was executed in Beijing On the same day, Shao Mingli, the successor director, signed the Bureau order No 28 to issue the new measures for the administration of drug registration Is it just a coincidence of time? Obviously not, it should be caused by the natural law of "the extremes of things must be reversed" At that time, a blogger named "popular monk" said: "from the perspective of industry observation, I also want to prompt a proposition that may be ignored by many people - that is the end of the old model of the pharmaceutical industry." The prediction of "monk" is too optimistic Eight years later, in 2015, and also in July, the State Food and Drug Administration issued a notice (No 117, 2015) on carrying out the self-examination and verification of drug clinical trial data The result is that 1622 (including chemical drugs) verification varieties are almost "annihilated" The "answer sheet" of 7.22 tells the world that the "old model" has not ended, and this industry has not been alerted by my old acquaintance "being pushed out of the Meridian Gate", let alone revived From a historical perspective, the real cause of the industry shock is the 7.22 verification, which may bring some hope to the industry So I would like to praise you for Lao Bi! [Note 1] Bi Jingquan, director of the State Food and drug administration, introduced the work of food and drug safety at the press conference of the new China food and Drug Administration on February 29, 2016 [Note 2] Wu Zhen made a speech at the press conference on August 18, 2015 when the State Council issued the opinions on reforming the review and approval system for pharmaceutical and medical devices.